Relationship between oxidized low-density lipoprotein antibodies and obesity in different glycemic situations
Abdullatif Taha Babakr,1 Osman Mohamed Elsheikh,2 Abdullah A Almarzouki,3 Adel Mohamed Assiri,1 Badr Eldin Elsonni Abdalla,4 Hani Yousif Zaki,5 Samir H Fatani,1 EssamEldin Mohamed NourEldin11Department of Medical Biochemistry, Faculty of Medicine, Umm Al-Qura University, Makkah, Kingdom of Saudi Ar...
Guardado en:
Autores principales: | Babakr AT, Elsheikh OM, Almarzouki AA, Assiri AM, Abdalla BE, Zaki HY, Fatani SH, NourEldin EM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/19d4be132d9d45c0be064c822daef317 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese
por: Dongway AC, et al.
Publicado: (2015) -
Testosterone, obesity, and waist circumference as determinants of metabolic syndrome in Saudi women
por: Fatani SH, et al.
Publicado: (2018) -
Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin
por: Yuan Y, et al.
Publicado: (2016) -
N-Succinyl-chitosan nanoparticles coupled with low-density lipoprotein for targeted osthole-loaded delivery to low-density lipoprotein receptor-rich tumors
por: Zhang CG, et al.
Publicado: (2014) -
Cysteamine Decreases Low‐Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low‐Density Lipoprotein Receptor–Deficient Mice
por: Feroz Ahmad, et al.
Publicado: (2021)